RE-BVS – Piemonte Repository

Sfoglia per AUTORE
SIENA S
Collezione ASL Biella

Items : 5

A precision medicine trial leveraging tissue and blood-based tumor genomics to optimize treatment in resected stage III and high-risk stage II colon cancer (CC) patients (pts): The SAGITTARIUS trial. in Journal of Clinical Oncology

2025
ASL Biella

Montagut CO; Tamberi S; Leone F; Libertini M; Negri F; Pastorino A; Siena S; Fenocchio E; Gennari A; Mandala M; Santoro A; Tarazona N; Elez E; Sartore-Bianchi A; Stintzing S; Muñoz S; Sibilio A; Silvestri Y; Lazzari L; Marsoni S;

45TiP A randomized, molecular driven phase II trial of carboplatin-paclitaxel-bev vs carboplatin-paclitaxel-bev-rucaparib vs carboplatin-paclitaxel-rucaparib, selected according to HRD status, in patients with advanced ovarian cancer in Annals of Oncology

2022
ASL Biella

Scambia G; Salutari V; Musacchio L; Siena S; Pignata S; Zavallone L; Valabrega G; Cormio G; Mosconi AM; Ricci C; Ghizzoni V; Carbone MV; Giudice E; Camarda F; Nero C; Tronconi F; Lorusso D;

Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trial. in ESMO open / ESMO Open. 2020 Sep;5(5):e000911. doi: 10.1136/esmoopen-2020-000911.

2020
ASL Biella

Sartore-Bianchi A; Lonardi S; Martino C; Fenocchio E; Tosi F; Ghezzi S; Leone F; Bergamo F; Zagonel V; Ciardiello F; Ardizzoni A; Amatu A; Bencardino K; Valtorta E; Grassi E; Torri V; Bonoldi E; Sapino A; Vanzulli A; Regge D; Cappello G; Bardelli A; Trusolino L; Marsoni S; Siena S;

Radiomics predicts response of individual HER2-amplified colorectal cancer liver metastases in patients treated with HER2-targeted therapy. in International journal of cancer / Int J Cancer. 2020 Dec 1;147(11):3215-3223. doi: 10.1002/ijc.33271. Epub 2020 Sep 14.

2020
ASL Cuneo 1
ASL Biella

Giannini V; Rosati S; Defeudis A; Balestra G; Vassallo L; Cappello G; Mazzetti S; De Mattia C; Rizzetto F; Torresin A; Sartore-Bianchi A; Siena S; Vanzulli A; Leone F; Zagonel V; Marsoni S; Regge D;

Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer. in Clinical colorectal cancer / Clin Colorectal Cancer. 2020 Dec;19(4):256-262.e2. doi: 10.1016/j.clcc.2020.06.009. Epub 2020 Jun 27

2020
ASL Biella

Tosi F; Sartore-Bianchi A; Lonardi S; Amatu A; Leone F; Ghezzi S; Martino C; Bencardino K; Bonazzina E; Bergamo F; Fenocchio E; Martinelli E; Troiani T; Siravegna G; Mauri G; Torri V; Marrapese G; Valtorta E; Cassingena A; Cappello G; Bonoldi E; Vanzulli A; Regge D; Ciardiello F; Zagonel V; Bardelli A; Trusolino L; Marsoni S; Siena S; et alii...